
MEDICINOVA INC — Investor Relations & Filings
MediciNova Inc. is a biopharmaceutical company focused on developing novel small molecule therapeutics for serious diseases with unmet medical needs. Its pipeline targets neurology, respiratory, and liver diseases. Key product candidates include MN-166 (ibudilast), which is being developed for indications such as Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis, Oncology/Glioblastoma, Chemotherapy-Induced Peripheral Neuropathy (CIPN), and Acute Respiratory Distress Syndrome (ARDS)/Lung Injury. MN-166 has also been marketed in Japan and Korea for post-stroke complications and bronchial asthma. Another candidate, MN-001 (tipelukast), is in development for Non-Alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes Mellitus, and Hypertriglyceridemia. The company's mission involves acquiring and accelerating the global development and commercialization of these therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| ARS | 2026-04-29 | English | |
| DEFA14A | 2026-04-29 | English | |
| DEF 14A | 2026-04-29 | English | |
| PRER14A | 2026-04-20 | English | |
| PRE 14A | 2026-04-17 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 46722291 | 10-Q | 2026-05-14 | English | ||
| 46722292 | ARS | 2026-04-29 | English | ||
| 46722293 | DEFA14A | 2026-04-29 | English | ||
| 46722295 | DEF 14A | 2026-04-29 | English | ||
| 46722297 | PRER14A | 2026-04-20 | English | ||
| 46722298 | PRE 14A | 2026-04-17 | English | ||
| 46722305 | 10-K | 2026-03-10 | English | ||
| 46722300 | 8-K | 2026-02-20 | English | ||
|
2025
7 filings
| |||||
| 46722307 | 424B5 | 2025-12-30 | English | ||
| 46722309 | 8-K | 2025-12-30 | English | ||
| 46722311 | Regulatory Filings 2025 | 2025-12-12 | English | ||
| 46722313 | S-3 | 2025-12-05 | English | ||
| 46722317 | 10-Q | 2025-11-12 | English | ||
| 46722318 | Regulatory Filings 2025 | 2025-10-01 | English | ||
| 46722321 | S-1 | 2025-08-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ascendis Pharma A/S
Biopharmaceutical firm using its prodrug technology to trea…
|
ASND | DK | Manufacturing |
|
Ascentage Pharma Group International
Integrated biopharma developing novel small molecule therap…
|
6855 | HK | Manufacturing |
|
ASCENTAGE PHARMA GROUP INTERNATIONAL
A clinical-stage biopharma developing novel therapies for c…
|
AAPG | US | Manufacturing |
|
Ascletis Pharma Inc.
R&D driven biotech developing best-in-class therapeutics, p…
|
1672 | KY | Manufacturing |
|
ASEP Medical Holdings Inc.
Developing diagnostic and therapeutic solutions to combat a…
|
ASEP | CA | Manufacturing |
|
ASKA Pharmaceutical Holdings CO., Ltd.
Specializes in hormone-related pharmaceuticals for internal…
|
4886 | JP | Manufacturing |
|
ASPEN PHARMACARE HOLDINGS LIMITED
Global specialty and branded pharmaceutical company deliver…
|
APN | ZA | Manufacturing |
|
Aspire Biopharma Holdings, Inc.
Develops sublingual drug delivery technologies for needle-f…
|
ASBP | US | Manufacturing |
|
ASSEMBLY BIOSCIENCES, INC.
A clinical-stage biotech developing small molecule antivira…
|
ASMB | US | Manufacturing |
|
ASSERCA S.R.L.
Specializes in importing, exporting, and manufacturing medi…
|
— | AR | Manufacturing |
MEDICINOVA INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72582/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72582 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72582 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72582 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72582}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MEDICINOVA INC (id: 72582)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.